19-42356864-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001271938.2(MEGF8):c.4713C>T(p.Ala1571Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00955 in 1,589,726 control chromosomes in the GnomAD database, including 133 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0070 ( 15 hom., cov: 32)
Exomes 𝑓: 0.0098 ( 118 hom. )
Consequence
MEGF8
NM_001271938.2 synonymous
NM_001271938.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.88
Publications
0 publications found
Genes affected
MEGF8 (HGNC:3233): (multiple EGF like domains 8) The protein encoded by this gene is a single-pass type I membrane protein of unknown function that contains several EGF-like domains, Kelch repeats, and PSI domains. Defects in this gene are a cause of Carpenter syndrome 2. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
MEGF8 Gene-Disease associations (from GenCC):
- MEGF8-related Carpenter syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, G2P, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
- Carpenter syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 19-42356864-C-T is Benign according to our data. Variant chr19-42356864-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 473333.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.88 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00699 (1064/152326) while in subpopulation SAS AF = 0.0337 (163/4834). AF 95% confidence interval is 0.0295. There are 15 homozygotes in GnomAd4. There are 551 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 15 AR gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MEGF8 | ENST00000251268.11 | c.4713C>T | p.Ala1571Ala | synonymous_variant | Exon 27 of 42 | 5 | NM_001271938.2 | ENSP00000251268.5 | ||
| MEGF8 | ENST00000334370.8 | c.4512C>T | p.Ala1504Ala | synonymous_variant | Exon 26 of 41 | 1 | ENSP00000334219.4 | |||
| MEGF8 | ENST00000378073.5 | c.-2373C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 27 of 41 | 5 | ENSP00000367313.4 | ||||
| MEGF8 | ENST00000378073.5 | c.-2373C>T | 5_prime_UTR_variant | Exon 27 of 41 | 5 | ENSP00000367313.4 |
Frequencies
GnomAD3 genomes AF: 0.00702 AC: 1069AN: 152208Hom.: 16 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1069
AN:
152208
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0102 AC: 2159AN: 212094 AF XY: 0.0120 show subpopulations
GnomAD2 exomes
AF:
AC:
2159
AN:
212094
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00982 AC: 14118AN: 1437400Hom.: 118 Cov.: 32 AF XY: 0.0107 AC XY: 7653AN XY: 712720 show subpopulations
GnomAD4 exome
AF:
AC:
14118
AN:
1437400
Hom.:
Cov.:
32
AF XY:
AC XY:
7653
AN XY:
712720
show subpopulations
African (AFR)
AF:
AC:
38
AN:
33036
American (AMR)
AF:
AC:
290
AN:
40808
Ashkenazi Jewish (ASJ)
AF:
AC:
463
AN:
25596
East Asian (EAS)
AF:
AC:
2
AN:
38382
South Asian (SAS)
AF:
AC:
2755
AN:
82126
European-Finnish (FIN)
AF:
AC:
139
AN:
51478
Middle Eastern (MID)
AF:
AC:
176
AN:
5724
European-Non Finnish (NFE)
AF:
AC:
9613
AN:
1100786
Other (OTH)
AF:
AC:
642
AN:
59464
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
848
1696
2544
3392
4240
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
378
756
1134
1512
1890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00699 AC: 1064AN: 152326Hom.: 15 Cov.: 32 AF XY: 0.00740 AC XY: 551AN XY: 74488 show subpopulations
GnomAD4 genome
AF:
AC:
1064
AN:
152326
Hom.:
Cov.:
32
AF XY:
AC XY:
551
AN XY:
74488
show subpopulations
African (AFR)
AF:
AC:
72
AN:
41554
American (AMR)
AF:
AC:
129
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
56
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5188
South Asian (SAS)
AF:
AC:
163
AN:
4834
European-Finnish (FIN)
AF:
AC:
25
AN:
10630
Middle Eastern (MID)
AF:
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
AC:
580
AN:
68028
Other (OTH)
AF:
AC:
26
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
53
105
158
210
263
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
39
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
MEGF8-related Carpenter syndrome Benign:2
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
Mar 22, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.